
April 15 (Reuters) - Arrowhead Pharmaceuticals Inc ARWR.O:
ARROWHEAD PHARMACEUTICALS INC - KEN MYSZKOWSKI TO RETIRE AS CFO OF ARROWHEAD PHARMACEUTICALS - SEC FILING
ARROWHEAD PHARMACEUTICALS INC - DANIEL APEL APPOINTED AS CFO OF ARROWHEAD PHARMACEUTICALS - SEC FILING
Source text: [ID:n0001628280-25-017844]